How many people are actually implanted?
One leading brain implant went from a single patient to about 28 in two years. The real count behind the headlines, step by step.
Full answer in the deck
LAST UPDATED: October 6, 2026
Get the latest reality check on neurotech
In neurotech the demonstrations travel much further than the patients. Everyone reads the headlines and misses where the revenue actually is. That leaves a lot of questions. You'll find the answers in this deck, just refreshed.
Get the market reportBought by people working at
BlackstonecitiFidelity
mastercardSamsungHYUNDAI
What's included in this report
Whether you end up investing in neurotech or building in it, we have you covered: twelve sections, the whole picture, updated.
- Market definitionWhat is this market about?Neurotech covers a device implanted in the brain, one threaded through a vein, and a headset you buy online. We start from a clear definition, so you know exactly what we are counting.
- Market opportunityWhere are the opportunities?A handful of companies have now put devices in people, and every one of those moments became a headline. We collected the latest signals and show you what is hot right now, and what is not anymore.
- Market sizeHow big is it really?The figures here come from counting potential patients and attaching a price that does not exist yet. We run our own first-principles analysis and show you the calculation, so you can trust the result.
- Pain pointsWhat are the problems to fix?A surgeon has to agree to operate, a hospital has to carry the risk, and no insurer covers this yet. We walk you through where the frustrations are, and who is ready to pay to fix them.
- Tech & infraWhat's the latest tech?Electrodes, decoding software, wireless power: each part works in a lab and gets much harder in a person. You will see where things stand today, what is still being built, and what comes next.
- Value creationWhich business models work?Nearly all the money in this field still comes from older implants, not from anything in the headlines. We give you the business models that work today, and where the money is really made.
- Market challengesWhat are the blockers?Brain surgery carries real risk, trials take years, and nobody has agreed to pay for any of it. We tell you what is still unsolved, what is already settled, and how much each one could slow this market down.
- Growth driversWhat are the growth drivers?Better decoding is what gets talked about, while surgeons and hospitals decide far more than that. We will show you what could make this market explode, and what is still missing to get there.
- Investor betsWhat do investors bet on?Almost all the money here goes to one or two names, which makes raising anywhere else hard. We will tell you what investors love right now, and what they will not look at anymore.
- Top playersWho are the startups?You know one name here. The teams with clearances and patients get a small fraction of the coverage. We show you the hottest startups, including the ones under the radar, on clear market maps.
- Startup killersWhat kills startups?A trial that stalls, a signal that fades after a year, and nobody willing to pay at the end. We will show you the patterns behind the failures, so you know what to watch for if you build or invest here.
- Startup strategiesHow to win this market?A few teams got devices into real patients while others are still presenting. We show you what the winners did differently, so you know what to reproduce.
Some of the questions we answer inside
A sample of six, from 194+ slides.
Does open-brain surgery block the market?
One startup reaches the brain through a vein, with no open surgery and just 16 electrodes. Why fewer channels can reach more people.
Full answer in the deck
What do regulators let companies sell?
China set BCI prices and approved the first implant for sale, while US rules move step by step. How the rules evolved, by region.
Full answer in the deck
Who would pay for a BCI implant?
No US insurer pays for implanted BCIs, and new uses wait years for payment. The eight reasons patients and doctors still stay away.
Full answer in the deck
Is an implant worth more than a device maker?
In eighteen months Neuralink went from 82% of Inspire Medical's value to twice as much, on two rounds.
Full answer in the deck
What is driving the interest in neurotech?
Searches for neurotechnology climbed with each implant announcement, far faster than patient numbers did.
Full answer in the deckWhy we built this deck
The part of neurotech that gets the most attention, brain implants, has striking demonstrations and almost no revenue. The money still comes from older neuromodulation devices, while implants that let paralyzed patients type remain limited to a small number of trial patients.
For years, neurotech mostly meant implanted stimulators for Parkinson’s, epilepsy and chronic pain, sold by a few large device makers. Now non-invasive and wearable devices are growing, and the well-funded implant companies still have to prove long-term safety before they can sell much.
If you’re building or investing in neurotech, you need to understand which approaches are likely to reach approval first, how insurers have paid for neuromodulation, and where the large medtech companies are placing their bets. We built this deck to give you that picture quickly, without making you read every trial registration. And because one clearance can change this market, we’ll send you the updated version every quarter.
Save hours of messy research
Weeks of reading, cross-checking and dead ends, already done. Here is what you can check for yourself on every page.
- One view instead of fifty tabsDozens of reports, filings and announcements compressed into a page you read in seconds
- The method is written downHow each number was built is explained on the slide, not hidden in a footnote
- Updated every single quarterNew rounds, new clearances, figures rechecked, and the date printed on the cover
- Our sources and databases are yoursLinks to every source we used, and to the databases behind them, so you can dig yourself
Questions?
What exactly do I get?
A 194+ slide PDF, downloadable right after checkout.
Who is this report for?
Founders, investors, operators and strategists who need a clear view of the market before they build, invest, partner or reposition.
What is your market definition?
Devices and software that read or modulate the nervous system for clinical use: implanted and endovascular brain-computer interfaces, neuromodulation, decoding software and surgical robotics. Consumer wellness headsets and general neuroscience tools are out.
Do you have funding data?
Yes, we have tracked every single deal, with all the available data: date, company, what it does, category, stage, deal size, HQ country and region, lead and strategic investors, founding year, etc. Email us and we'll send it to you.
Do you have startup data?
Yes, we rank every company we follow, with revenue, valuation and multiple numbers, plus category and segment, so you can sort and compare instead of reading a list. Email us and we'll send it to you.
Can I get future updates?
Yes. We update every deck each quarter. With the complete deck, just send us an email and we'll send you the next update, along with the latest version of both databases.
Can I get a company invoice?
Yes. Add your company name at checkout, or email us and we'll send one.
Any guarantee?
If the deck doesn't hold up to what this page shows, tell us and we'll refund you. No forms.
Is this a one-time payment?
Yes, both options are a single payment. Nothing renews, nothing is charged again, and there is nothing to cancel.
Can I get a discount?
Yes. Use NEWMARKET for 20% off two reports, or NEWMARKETMAX for 30% off five or more. The codes work on any mix of markets.
Still have a question?
Email team@newmarketpitch.com and we reply within 24 hours.
Get the neurotech market report
This market confuses a lot of smart people. A device can work perfectly and still have no one willing to pay for it. Here, you'll get the latest update, with the real numbers you need.
A snapshot of today
The essentials
6 of the 12 sections — Updated 6 days ago
$79one-time
Updated 6 days ago
- Market definition
- Market opportunity
- Market size
- Pain points
- Tech & infra
- Value creation
- Market challenges
- Growth drivers
- Investor bets
- Top players
- Startup killers
- Startup strategies
The full picture
The complete deck
All 12 sections — Updated 6 days ago
$99one-time
Updated 6 days ago
- Market definition
- Market opportunity
- Market size
- Pain points
- Tech & infra
- Value creation
- Market challenges
- Growth drivers
- Investor bets
- Top players
- Startup killers
- Startup strategies
BONUS
- We can send you the next updates
- Full access to funding and startup data
Use code MARKETPITCH for 10% off your order